Topical Mechlorethamine Restores Autoimmune-Arrested Follicular Activity in Mice with an Alopecia Areata-Like Disease by Targeting Infiltrated Lymphocytes

    Lisa Tang, Liping Cao, Olga Bernardo, Yongliang Chen, John P. Sundberg, Harvey Lui, Stephen W. Chung, Jerry Shapiro
    New to Alopecia Areata? There is a guide in the encyclopedia. Read the guide →
    Image
    Studysummary This study found that mechlorethamine restored hair growth in mice with alopecia-areata-like disease by eliminating infiltrated lymphocytes and inhibiting certain pro-inflammatory cytokines in treated skin areas.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    In the 2003 study, 24 female C3H/HeJ mice with an induced alopecia areata-like disease were treated with topical mechlorethamine. The treatment led to full hair regrowth on the treated side of the mice after 10 weeks, while the control side showed no improvement. The study demonstrated that mechlorethamine effectively eliminated CD4 and CD8+ lymphocytes from the skin, which are key in the disease's progression, and was more cytotoxic to lymphocytes than to skin and follicular cells. Additionally, mechlorethamine reduced the production of inflammatory cytokines such as TNF-α/β, IL-12, and IFN-γ. These results suggest that mechlorethamine can selectively target the immune cells responsible for hair loss in alopecia areata without damaging hair follicles and may offer a potential treatment for the condition by inhibiting inflammatory cytokines.
    Discuss this study in the Community →

    Research cited in this study

    6 / 6 results